Back to Search Start Over

An unusual case of primary hepatic lymphoma with dramatic but unsustained response to bendamustine plus rituximab and literature review

Authors :
Sih-Han Liao
Yin-Kai Chen
Shan-Chi Yu
Ming-Shiang Wu
Hsiu-Po Wang
Ping-Huei Tseng
Source :
SAGE Open Medical Case Reports, Vol 5 (2017)
Publication Year :
2017
Publisher :
SAGE Publishing, 2017.

Abstract

Objectives: Primary hepatic lymphoma is an uncommon cause of hepatic space-occupying lesions. Methods: We describe the case of a 73-year-old man with primary hepatic lymphoma, who presented with a low-grade fever and lower limb weakness which had progressed in the past 2 months. Results: Abdominal ultrasound and computed tomography showed multiple small hepatic tumors. Echo-guided biopsy of the hepatic tumor demonstrated primary hepatic diffuse large B cell lymphoma. Moreover, bone marrow was uninvolved, but the bone marrow smear disclosed hemophagocytosis, which is uncommon in diffuse large B cell lymphoma. Chemotherapy with bendamustine and rituximab treatment was initiated with a dramatic response: hepatic tumors markedly shrank in size shown by follow-up computed tomography and the patient returned to his normal life. Nevertheless, the response was sustained for only 8 months. Finally, the disease resisted further chemotherapy and this patient died of a severe Klebsiella pneumoniae infection. Conclusion: Chemotherapy with bendamustine and rituximab has shown a dramatic, but not durable, response in the present case with old age and multiple comorbidities.

Subjects

Subjects :
Medicine (General)
R5-920

Details

Language :
English
ISSN :
2050313X
Volume :
5
Database :
Directory of Open Access Journals
Journal :
SAGE Open Medical Case Reports
Publication Type :
Academic Journal
Accession number :
edsdoj.104faa994185446a81d670a2a405fbbd
Document Type :
article
Full Text :
https://doi.org/10.1177/2050313X17709190